Medtronic Deferred Revenue increased by 33.3% to $400.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $400.00M to $400.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_current| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $1.10B | $1.00B | $801.00M | $719.00M | $662.00M | $600.00M | $500.00M | $500.00M | $400.00M | $400.00M | $400.00M | $400.00M | $300.00M | $400.00M |
| QoQ Change | — | -8.3% | -9.1% | -19.9% | -10.2% | -7.9% | -9.4% | -16.7% | +0.0% | -20.0% | +0.0% | +0.0% | +0.0% | -25.0% | +33.3% |
| YoY Change | — | — | — | -33.3% | -34.6% | -33.8% | -25.1% | -30.5% | -24.5% | -33.3% | -20.0% | -20.0% | +0.0% | -25.0% | +0.0% |